Navigation Links
The genomics symposium to boost the further development of cancer research
Date:7/3/2012

July 3, 2012, London, United Kingdom, and Shenzhen, China The symposium themed "The Era of Next Generation Sequencing in Cancer", co-organized by BGI, the world's largest genomics organization, and Imperial College London, was successfully conducted in London, UK. Around 70 experts, scholars, and representatives from the local colleges, institutes and biotechnology industries attended the meeting with the aim to exchange their insights on high-throughput genomics and accelerate the further development of cancer research.

The symposium started with a friendly opening remark by Professor Charles Coombes, Director of Division of Cancer, Imperial College, and Hon Consultant Medical Oncologist, Imperial College Healthcare Trust. He was delighted to be the chairman of the symposium, and said:" The symposium is a good start between Imperial College London and BGI. We are looking forward to more collaboration with BGI, one of the largest genomics organizations in the world. We are confident that we will make more breakthroughs together in the near future."

After that, experts delivered several excellent presentations highlighting the advancements in cancer research, including "Cancer genome research in BGI", "Understanding estrogen receptor transcription in breast cancer", "Genetic analysis of five cancers using single-cell sequencing", "Genetic regulation of the rat cardiac methylome", "Personalized epigenetic therapy in follicular lymphoma", "Biomarker discovery through integrated next-generation sequencing (NGS) genomic analysis of neuroendocrine tumors", among others.

Yingrui Li, Vice Director of BGI, shared several case studies on cancer genome research applying BGI's NGS and bioinformatics technologies. He referred that the object of their studies is to make more contributions in cancer research and boost the transformation of scientific discoveries to benefit human health. He emphasized that, "NGS technologies, especially single-cell sequencing technology, elevate cancer research to a new level, enabling researchers to conduct cancer studies for the treatment and diagnosis of cancer at the cellular level and whole-genome level."

Cancer genome research has been one of the most important fields in life science. With the rapid development of the NGS technologies, it allows researchers to comprehensively explore the characteristics underlying cancers. The symposium brought together leading scientists and researchers from UK and China, providing a truly international platform for strengthening the academic cooperation and communication between the two countries.


'/>"/>

Contact: Jia Liu
liujia@genomics.cn
BGI Shenzhen
Source:Eurekalert

Related biology news :

1. SDSCs big data expertise aiding genomics research
2. BGI, University of Helsinki and Wuhan University sign a MOU concerning cooperation on genomics
3. In search for a vaccine, IU biologist receives $2.3 million to explore chlamydia genomics
4. ACRG and BGI report findings from genomics research on recurrent hepatitis B virus integration
5. 5th Annual Advances in Biomolecular Engineering Symposium
6. Science, Innovation, and Partnerships for Sustainability -- Symposium May 16-18
7. Coral reef experts to present latest coral reef science during July symposium
8. FirstMark Exhibiting and Presenting at the San Diego Academy of Family Physicians 55th Annual Postgraduate Symposium
9. Topics to be discussed during July International Coral Reef Symposium
10. MARC Travel Awards announced for the 26th Annual Symposium of the Protein Society
11. New method for estimating parameters may boost biological models
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2016)... 2016 Favorable Government Initiatives Coupled ... Criminal Identification to Boost Global Biometrics System Market Through ... Research report, " Global Biometrics Market By Type, ... Opportunities, 2011 - 2021", the global biometrics market is ... account of growing security concerns across various end use ...
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016 On ... session at 4,833.32, down 0.22%; the Dow Jones Industrial Average ... 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez ... Inc. (NASDAQ: BIND ). Learn more about these ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
(Date:6/23/2016)... 2016  Amgen (NASDAQ: AMGN ) today ... life sciences incubator to accelerate the development of ... space at QB3@953 was created to help high-potential life ... many early stage organizations - access to laboratory infrastructure. ... launched two "Amgen Golden Ticket" awards, providing each winner ...
(Date:6/22/2016)... , June 22, 2016 Cell Applications, ... allow them to produce up to one billion ... lot within one week. These high-quality, consistent stem ... preparing cells and spend more time doing meaningful, ... a proprietary, high-volume manufacturing process that produces affordable, ...
Breaking Biology Technology: